Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD

Bone Marrow Transplant. 2012 May;47(5):737-8. doi: 10.1038/bmt.2011.150. Epub 2011 Jul 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Drug Resistance
  • Graft vs Host Disease / complications*
  • Graft vs Host Disease / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Rituximab
  • Scleroderma, Localized / drug therapy*
  • Scleroderma, Localized / etiology
  • Skin Diseases / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab